Article

Orientia tsutsugamushi Ank5 directs ubiquitination and proteasomal degradation of NLRC5 to…

medRxiv · 2023 · Adcox, H.; Hunt, J. R.; Rodino, K. G.; Ottens, A. K.; Carlyon, J. A.

Key facts

Title Orientia tsutsugamushi Ank5 directs ubiquitination and proteasomal degradation of NLRC5 to inhibit major histocompatibility complex class I expression
First author Adcox, H.; Hunt, J. R.; Rodino, K. G.; Ottens, A. K.; Carlyon, J. A.
Journal medRxiv
Published Dec 6, 2023
DOI 10.1101/2023.12.04.569938
Devices mentioned BK110039, DEN000008, K022086, K103302
Product codes mentioned JCI, JJH, KIP, KIT, MVU, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature